BBlogFlow

Do Islanders benefit from some privatized health care? Maple's CEO says yes - CBC

·Oct 6, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesDisability LifeGo PublicAbout CBC NewsBeing Black in CanadaVideoDo Islanders benefit from some privatized health care? Maple's CEO says yes | CBC.ca LoadedDo Islanders benefit from some privatized health care? Maple's CEO says yesOctober 6|Duration 7:04October 6NewsDuration 7:04closed captionPublic-private health-care partnerships are expanding on P. E. I., offering everything from MRIs to cataract surgeries. CBC News: Compass host Louise Martin speaks with Dr. Brett Belchetz, the CEO of virtual-care platform Maple, who says it's time to stop demonizing private health companies. Related Stories'Attached to a team': One patient medical home will take a new approach to Islanders' health careWhat is Health P. E. I. doing to bring doctors to the province? Not enough, say some MLAsP. E. I. gets $32M to keep prescription drugs more affordable for IslandersP. E. I. is adding lots of new long-term care beds — but will they be enough?

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Opinion: Parallel privatized health-care systems like Alberta's don't reduce wait times - Vancouver Sun

Skip to Content Subscribe FAQ My Account Manage My Subscriptions Our Offers News Local News Politics Health Local Health National True Crime Crime World Education Weather Podcasts BC Public Sector Salaries Database Archives Contact the Newsroom Sports Vancouver Canucks NHL PWHL More Hockey BC Lions CFL NFL Vancouver Whitecaps Soccer Baseball Basketball NBA Golf MMA Curling Tennis Auto Racing Arts Local Arts Music Theatre Festivals Books Celebrity Movies Television TV Listings Life Travel Local Travel Travel Canada Travel USA Travel International Cruises Travel Essentials Food Local Food Reviews Recipes Wine Country Salut!

Vancouver Sun·

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·